Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11

Vaccine

Volumn 34, Issue 7, 2016, Pages 981-988

  Thompson, Mark G ^a   Naleway, Allison ^b   Fry, Alicia M ^a   Ball, Sarah ^c   Spencer, Sarah M ^a   Reynolds, Sue ^a   Bozeman, Sam ^b   Levine, Min ^a   Katz, Jacqueline M ^a   Gaglani, Manjusha ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

^c ABT ASSOCIATES   (United States)

^d SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Healthcare personnel; Hemagglutination inhibition antibody; Immunogenicity; Influenza vaccination

Indexed keywords

INFLUENZA VACCINE; INACTIVATED VACCINE; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; DRUG EFFECT; FEMALE; HEALTH CARE PERSONNEL; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA A VIRUS (H3N2); INFLUENZA VACCINATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; ANTIBODY PRODUCTION; BLOOD; DOSE RESPONSE; INFLUENZA, HUMAN; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; VACCINATION;

ADULT; ANTIBODIES, VIRAL; ANTIBODY FORMATION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HEALTH PERSONNEL; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VACCINATION; VACCINES, INACTIVATED;

EID: 84957818597     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.10.119     Document Type: Article

References (38)

1. Smith D.J., Forrest S., Ackley D.H., Perelson A.S. Variable efficacy of repeated annual influenza vaccination. Proceedings of the National Academy of Sciences of the United States of America 1999 Nov 23, 96(24):14001-14006.
2. Beyer W.E., de Bruijn I.A., Palache A.M., Westendorp R.G., Osterhaus A.D. Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies. Archives of internal medicine 1999 Jan 25, 159(2):182-188.
3. Sullivan S.G., Kelly H. Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2013 Aug, 57(3):474-476.
4. Gaglani M., Spencer S., Ball S., Song J., Naleway A., Henkle E., et al. Antibody Response to Influenza A(H1N1)pdm09 Among Healthcare Personnel Receiving Trivalent Inactivated Vaccine: Effect of Prior Monovalent Inactivated Vaccine. The Journal of infectious diseases 2014 Jun, 209(11):1705-1714.
5. Ohmit S.E., Thompson M.G., Petrie J.G., Thaker S.N., Jackson M.L., Belongia E.A., et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2014 Feb, 58(3):319-327.
6. Thompson M.G., Li D.K., Shifflett P., Sokolow L.Z., Ferber J.R., Kurosky S., et al. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2014 Feb, 58(4):449-457.
7. Ohmit S.E., Petrie J.G., Malosh R.E., Cowling B.J., Thompson M.G., Shay D.K., et al. Influenza vaccine effectiveness in the community and the household. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2013 May, 56(10):1363-1369.
8. Skowronski D.M., Janjua N.Z., De Serres G., Sabaiduc S., Eshaghi A., Dickinson J.A., et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PloS one 2014, 9(3):e92153.
9. McLean HQ, Thompson MG, Sundaram ME, Meece JK, McClure DL, Friedrich TC, et al. Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2014 Sep 29.
10. De Bruijn I.A., Remarque E.J., Jol-van der Zijde C.M., van Tol M.J., Westendorp G.G., Knook D.L. Quality and quantity of the humoral immune respose in healthy elderly and young subjects after annually repeated influenza vaccination. Journal of Infectious Diseases 1999, 179:31-36.
11. Gardner E.M., Bernstein E.D., Dran S., Munk G., Gross P., Abrutyn E., et al. Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population. Vaccine 2001 Sep 14, 19(32):4610-4617.
12. Pyhala R., Kumpulainen V., Alanko S., Forsten T. HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992. Vaccine 1994 Aug, 12(10):947-952.
13. Beyer W.E., Palache A.M., Sprenger M.J., Hendriksen E., Tukker J.J., Darioli R., et al. Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine 1996 Oct, 14(14):1331-1339.
14. Kunzel W., Glathe H., Engelmann H., Van Hoecke C. Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine 1996 Aug, 14(12):1108-1110.
15. Keitel W.A., Cate T.R., Couch R.B., Huggins L.L., Hess K.R. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 1997 Jul, 15(10):1114-1122.
16. Song J.Y., Cheong H.J., Hwang I.S., Choi W.S., Jo Y.M., Park D.W., et al. Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence. Vaccine 2010 May 21, 28(23):3929-3935.
17. Huijskens E., Rossen J., Mulder P., van Beek R., van Vugt H., Verbakel J., et al. Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population. Clinical and vaccine immunology: CVI 2011 Sep, 18(9):1401-1405.
18. Laguio-Vila M TM, Reynolds S, Spencer SS, et al. Comparison of Serum Hemagglutinin and Neuraminidase Inhibition Antibody Production Following 2010-2011 Trivalent Inactivated Influenza Vaccination among Healthcare Personnel. CID IN REVIEW.
19. Thompson M.G., Gaglani M.J., Naleway A., Ball S., Henkle E.M., Sokolow L.Z., et al. The expected emotional benefits of influenza vaccination strongly affect pre-season intentions and subsequent vaccination among healthcare personnel. Vaccine 2012 May 21, 30(24):3557-3565.
20. Henkle E., Irving S.A., Naleway A.L., Gaglani M.J., Ball S., Spencer S., et al. Comparison of laboratory-confirmed influenza and noninfluenza acute respiratory illness in healthcare personnel during the 2010-2011 influenza season. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America 2014 May, 35(5):538-546.
21. Thompson M.G., Gaglani M.J., Naleway A., Thaker S., Ball S. Changes in Self-Rated Health and Subjective Social Status over Time in a Cohort of Healthcare Personnel. Journal of health psychology 2013 May 16.
22. Thompson M.G., Naleway A., Ball S., Henkle E.M., Sokolow L.Z., Williams J., et al. Subjective social status predicts wintertime febrile acute respiratory illness among women healthcare personnel. Health psychology: official journal of the Division of Health Psychology. American Psychological Association 2014 Mar, 33(3):282-291.
23. Haaheim L.R., Katz J.M. Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1-3, 2010. Influenza Other Respir Viruses 2011 Jul, 5(4):288-295.
24. Network WHOGIS. Serological diagnosis of influenza by haemagglutination inhibition testing. In: Manual for the laboratory diagnosis and virological surveillance of influenza. Geneva, Switzerland: WHO; 2011.
25. Coudeville L., Bailleux F., Riche B., Megas F., Andre P., Ecochard R. Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model. BMC medical research methodology 2010, 10:18.
26. Beyer W.E., Palache A.M., Luchters G., Nauta J., Osterhaus A.D. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?. Virus research 2004 Jul, 103(1-2):125-132.
27. Ohmit S.E., Petrie J.G., Malosh R.E., Fry A.M., Thompson M.G., Monto A.S. Influenza Vaccine Effectiveness in Households with Children during the 2012-2013 Season: Assessments of Prior Vaccination and Serologic Susceptibility. The Journal of infectious diseases 2015 Nov 21, 211:1519-1528.
28. Ohmit S.E., Petrie J.G., Cross R.T., Johnson E., Monto A.S. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. The Journal of infectious diseases 2011 Dec 15, 204(12):1879-1885.
29. Sasaki S., He X.S., Holmes T.H., Dekker C.L., Kemble G.W., Arvin A.M., et al. Influence of prior influenza vaccination on antibody and B-cell responses. PloS one 2008, 3(8):e2975.
30. Uhr J.W., Moller G. Regulatory effect of antibody on the immune response. Advances in immunology 1968, 8:81-127.
31. Chen Z., Zhou H., Jin H. The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response. Vaccine 2010 May 28, 28(24):4079-4085.
32. Lessler J., Riley S., Read J.M., Wang S., Zhu H., Smith G.J., et al. Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China. PLoS pathogens 2012, 8(7):e1002802.
33. Kucharski A.J., Gog J.R. The role of social contacts and original antigenic sin in shaping the age pattern of immunity to seasonal influenza. PLoS computational biology 2012, 8(10):e1002741.
34. Ahmed F., Lindley M.C., Allred N., Weinbaum C.M., Grohskopf L. Effect of influenza vaccination of healthcare personnel on morbidity and mortality among patients: systematic review and grading of evidence. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2014 Jan, 58(1):50-57.
35. Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morbidity and mortality weekly report 2010 Aug 27;59(33):1057-62.
36. Interim adjusted estimates of seasonal influenza vaccine effectiveness-United States, February 2013. MMWR Morbidity and mortality weekly report 2013 Feb 22;62(7):119-23.
37. Beyer W.E., Nauta J.J., Palache A.M., Giezeman K.M., Osterhaus A.D. Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and meta-analysis. Vaccine 2011 Aug 5, 29(34):5785-5792.
38. McLean H.Q., Thompson M.G., Sundaram M.E., Kieke B.A., Gaglani M., Murthy K., et al. Influenza Vaccine Effectiveness in the United States During 2012-2013: Variable Protection by Age and Virus Type. The Journal of infectious diseases 2014 Nov 18.